Skip to main content

Table 3 Proportion of retention and attrition after ART initiation in the follow-up period by coinfection status and gender, in Addis Ababa, Ethiopia, (September 2011 to December 2018)

From: Retention on antiretroviral therapy in person with HIV and viral hepatitis coinfection in Ethiopia: a retrospective cohort study

Outcome

Coinfection, (n = 132)

Monoinfection, (n = 514)

Male

Female

Total

Male

Female

Total

n (%), 95%: CI

Retention

at 12 months

62(77.50)

[66.8–85.4]

45(86.53)

[73.8–93.6]

107(81.06)

[73.3–86.9]

195(86.66)

[81.5–90.5]

251(87.15)

[82.7–90.5]

446(86.96)

[83.7–89.6]

Cumulative retention

80(61.25)

[49.9–71.4]

52(80.76)

[67.3–89.5]

132(68.93)

[60.4–76.3]

225(77.77)

[71.8–82.7]

289(82.29)

[77.4–86.3]

514(80.35)

[76.6–83.5]

LTFU

LTFU at 12 months

17.5

[10.5–27.6]

7.69

[2.8–19.3]

13.63

[8.7–20.7]

10.66

[7.2–15.4]

9.72

[6.7–13.7]

10.11

[7.7–13.0]

Cumulative LTFU

31.25c

[20.8–41.6]

13.46c

[3.8–23.0]

24.24d

[16.8–31.6]

19.55

[14.3–24.7]

14.58

[10.4–18.6]

16.73d

[13.4–19.9]

Death

      

Death at 12 months

5.0

[1.8–12.8]

5.76

[1.8–16.97]

5.3e

[2.5–10.8]

2.66

[1.19–5.8]

3.12

[1.-6–5.9]

2.91e

[1.76–4.7]

A cumulative death

7.5

[3.3–15.9]

5.76

[1.8–16.9]

6.81

[3.5–12.6]

2.66

[1.1–5.8]

3.12

[1.6–5.9]

2.91

[1.7–4.7]

  1. HIV-Monoinfection: negative for both hepatitis B virus and hepatitis C viruses; HIV-Coinfection: hepatitis B virus or hepatitis C virus positive; LTFU loss to follow-up c Compared LTFU between male and female in co-infected group and there is a significant difference with a p-value < 0.0203 d compared LTFU in coinfected versus monoinfected and there is a significant difference with a p-value (0.0318). e Compared death in coinfected versus monoinfected and there is a significant statistical association